| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,072,000 | 1,050,000 | 1,035,000 | 1,042,000 | | Cost of Revenue | 132,000 | 133,000 | 141,000 | 146,000 | | | Gross Profit | 940,000 | 917,000 | 894,000 | 896,000 | | | Operating Expenses | | Research Development | 115,000 | 119,000 | 128,000 | 115,000 | | Selling General and Administrative | 420,000 | 391,000 | 421,000 | 417,000 | | Non Recurring | (7,000) | 9,000 | 91,000 | (12,000) | | Others | 73,000 | 73,000 | 74,000 | 67,000 | | | | Total Operating Expenses | 601,000 | 592,000 | 714,000 | 587,000 | | | | Operating Income or Loss | 339,000 | 325,000 | 180,000 | 309,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 339,000 | 325,000 | 180,000 | 309,000 | | Interest Expense | 22,000 | 17,000 | 11,000 | 8,000 | | Income Before Tax | 317,000 | 308,000 | 169,000 | 301,000 | | Income Tax Expense | 99,000 | 113,000 | 97,000 | 88,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 218,000 | 195,000 | 72,000 | 213,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 218,000 | 195,000 | 72,000 | 213,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $218,000 | $195,000 | $72,000 | $213,000 |
|
0.83% Nasdaq 0.00%
Income Statement
